Mohamed Zaki's most recent trade in Adc Therapeutics SA was a trade of 230,000 Common Shares done at an average price of $1.6 . Disclosure was reported to the exchange on Feb. 13, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Adc Therapeutics SA | Mohamed Zaki | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 1.61 per share. | 13 Feb 2025 | 230,000 | 462,888 | - | 1.6 | 370,300 | Common Shares |
Adc Therapeutics SA | Mohamed Zaki | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.13 per share. | 06 Dec 2024 | 37,112 | 232,888 | - | 3.1 | 116,161 | Common Shares |